The incidental discovery of follicular thyroid cancer with In-111 pentetreotide scintigraphy in a patient with carcinoid tumor of the lung

被引:4
作者
Villa, G
Ratto, GB
Carletto, M
Rouhanifar, H
Piccardo, A
Tommasi, L
Altrinetti, V
Mereu, C
Mariani, G
机构
[1] Univ Genoa, Sch Med, DIMI,Div Thorac Surg, Nucl Med Serv, I-16132 Genoa, Italy
[2] Univ Genoa, Sch Med, DIMI, Div Pneumol, I-16132 Genoa, Italy
关键词
carcinoid tumor; follicular thyroid cancer; In-111; pentetreotide; somatostatin receptor scintigraphy;
D O I
10.1097/00003072-200301000-00012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Although scintigraphy with the somatostatin receptor agent In-111 pentetreotide is most useful in patients with amine precursor uptake and decarboxylation-derived tumors, several reports note the tumor-targeting potential of this radiopharmaceutical in other types of cancers as well. The authors describe a 38-year-old woman with carcinoid tumor of the lung in whom scintigraphy with labeled pentetreotide was positive in the known lung tumor and incidentally revealed uptake in a thyroid nodule. Although the serum calcitonin level was normal, fine-needle cytology of the thyroid nodule was consistent with follicular cancer. The patient underwent resection of the lower lobe of the left lung and total thyroidectomy, which confirmed a follicular cancer in the right thyroid lobe.
引用
收藏
页码:45 / 46
页数:2
相关论文
共 7 条
[1]  
Forssell-Aronsson EB, 2000, J NUCL MED, V41, P636
[2]   Uptake of In-111 pentetreotide by normally functioning nodular goiters [J].
Garancini, S ;
LaRosa, S ;
DePalma, D ;
Uccela, S ;
Golonia, F .
CLINICAL NUCLEAR MEDICINE, 1997, 22 (09) :625-627
[3]  
Görges R, 1999, NUKLEARMED, V38, P15
[4]   Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer [J].
Görges, R ;
Kahaly, G ;
Müller-Brand, J ;
Mäcke, H ;
Roser, HW ;
Bockisch, A .
THYROID, 2001, 11 (07) :647-659
[5]  
LAMBERTS SWJ, 1990, NEW ENGL J MED, V323, P652
[6]  
Limouris GS, 1997, ANTICANCER RES, V17, P1593
[7]   Somatostatin and somatostatin analogues in medullary thyroid carcinoma [J].
OByrne, KJ ;
OHare, N ;
Sweeney, E ;
Freyne, PJ ;
Cullen, MJ .
NUCLEAR MEDICINE COMMUNICATIONS, 1996, 17 (09) :810-816